Page last updated: 2024-08-17

methacholine chloride and enalaprilat anhydrous

methacholine chloride has been researched along with enalaprilat anhydrous in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, NJ; Pretorius, M; Rosenbaum, D; Vaughan, DE	1
Brown, NJ; Luther, JM; Murphey, LJ; Pretorius, M; Vaughan, DE	1
Brown, NJ; Byrd, JB; Gainer, JV; Hill, K; Luther, JM; Pretorius, M; Van Guilder, GP	1
Brown, NJ; Guzman, RJ; Luther, JM; Pretorius, M; van Guilder, GP	1

Trials

3 trial(s) available for methacholine chloride and enalaprilat anhydrous

Article	Year
Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Circulation, 2003, Feb-04, Volume: 107, Issue:4 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Bradykinin; Bradykinin Receptor Antagonists; Dose-Response Relationship, Drug; Enalaprilat; Endothelium, Vascular; Female; Fibrinolysis; Forearm; Humans; Infusions, Intra-Arterial; Male; Methacholine Chloride; Muscarinic Agonists; Regional Blood Flow; Smoking; Tissue Plasminogen Activator; Vascular Resistance	2003
Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:11 Topics: Adult; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Enalaprilat; Female; Humans; Luteal Phase; Male; Methacholine Chloride; Middle Aged; Nitroprusside; Parasympathomimetics; Peptide Fragments; Peptidyl-Dipeptidase A; Postmenopause; Premenopause; Regional Blood Flow; Sex Characteristics; Tissue Plasminogen Activator; Vasodilator Agents	2005
17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:4 Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Drug Interactions; Enalaprilat; Estradiol; Estrogens; Female; Humans; Methacholine Chloride; Middle Aged; Nitroprusside; Parasympathomimetics; Peptidyl-Dipeptidase A; Postmenopause; Regional Blood Flow; Tissue Plasminogen Activator; Vasodilator Agents	2008

Other Studies

1 other study(ies) available for methacholine chloride and enalaprilat anhydrous

Article	Year
Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:2 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Drug Synergism; Enalaprilat; Endothelium, Vascular; Female; Forearm; Genotype; Humans; Injections, Intra-Arterial; Male; Methacholine Chloride; Nitroprusside; Polymorphism, Genetic; Receptor, Bradykinin B2; Regional Blood Flow; Sex Factors; Tissue Plasminogen Activator; Vascular Resistance; Vasodilation; Vasodilator Agents	2008

Article

Year

Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.

Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:2

Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Drug Synergism; Enalaprilat; Endothelium, Vascular; Female; Forearm; Genotype; Humans; Injections, Intra-Arterial; Male; Methacholine Chloride; Nitroprusside; Polymorphism, Genetic; Receptor, Bradykinin B2; Regional Blood Flow; Sex Factors; Tissue Plasminogen Activator; Vascular Resistance; Vasodilation; Vasodilator Agents

2008